Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Management of cardiovascular disease in patients with HIV is based on research conducted in the general population
  • Recommended approach involves risk-factor reduction, use of antiplatelet therapy, beta-blockers, angiotensin inhibitors or angiotensin receptor blockers, statins or antilipidic agents, and other interventions where necessary (Table 12)[Smith 2006; ACC/AHA 2013]
  • Referral to a cardiologist is recommended in patients with established coronary artery disease or when baseline evaluation is suggestive of disease

Action required

Keywords: Cardiovascular Disease, Treatment Complications

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.